No definition available.
Fetus and newborn affected by maternal complications of pregnancy
P16_FET_NEWB_MATERN_COMPLICATIO_PREGNAC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
231 |
4. Check minimum number of eventsNone |
231 |
5. Include endpointsNone |
231 |
6. Filter based on genotype QC (FinnGen only) |
231 |
Control definitions (FinnGen only)
- Control exclude
- P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P0[0-4]
- Name in latin
- Fetus et neonatus complicationibus graviditatis maternis affectus
Similar endpoints
↥List of similar endpoints to
Fetus and newborn affected by maternal complications of pregnancy
based on the number of shared cases.
Similar with more cases:
- Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 19742 | 9127 | 10615 |
| Only index persons | 7988 | 3741 | 4247 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.28 | 0.26 | 0.30 |
| Only index persons | 0.15 | 0.14 | 0.16 |
| Median age at first event (years) | |||
| Whole population | - | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 231 | 135 | 96 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 197
- Matched controls
- 1968
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P01.5
ICD-10 Finland
Fetus and newborn affected by multiple pregnancy
+∞
104.8
91
*
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
+∞
87.1
77
*
P07.3
ICD-10 Finland
Other preterm infants
42.1
84.3
108
55
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
13.2
37.1
70
79
P07.11
ICD-10 Finland
Other low birth weight 1500-1999 g
31.5
19.3
25
9
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
12.0
16.4
30
29
P07.12
ICD-10 Finland
Other low birth weight 2000-2499 g
14.1
14.9
25
20
WX722
NOMESCO Finland
PEEP
8.0
14.4
33
48
P39.9
ICD-10 Finland
Infection specific to the perinatal period, unspecified
14.9
11.7
19
14
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
7.6
10.8
25
37
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.7
10.6
37
92
P07.1
ICD-10 Finland
Other low birth weight
38.6
9.1
11
*
WW805
NOMESCO Finland
Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse
29.0
8.6
11
*
A11JC
ATC
Vitamins, other combinations
23.2
8.1
11
5
P05.1
ICD-10 Finland
Small for gestational age
10.0
7.9
15
16
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
7.2
7.8
18
27
P07.2
ICD-10 Finland
Extreme immaturity
12.5
7.7
13
11
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
11.5
7.4
13
12
P01.11
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes more than 7 days before delivery
+∞
7.3
7
*
P03.4
ICD-10 Finland
Fetus and newborn affected by caesarean delivery
+∞
7.3
7
*
P00.0
ICD-10 Finland
Fetus and newborn affected by maternal hypertensive disorders
+∞
7.3
7
*
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
20.9
7.2
10
5
WX882
NOMESCO Finland
High dependency care
2.9
7.0
46
189
R4110
NOMESCO Finland
Physiotherapy
2.4
6.9
66
337
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
6.5
49
217
P36.90
ICD-10 Finland
Suspected bacterial sepsis of newborn
9.7
6.4
12
13
P07.10
ICD-10 Finland
Other low birth weight 1000-1499 g
13.1
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002582) Erythrocytes [#/volume] in Urine
84
611
1.59
2.77
4.8
5.3
e6/l
17.2
25.4
0.49
60
464
(3030467) Casts [#/volume] in Urine by Automated count
79
573
1.57
2.62
4.1
5.1
e6/l
0.3
0.3
0.05
55
429
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
100
2.09
2.28
1.6
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
100
2.09
2.28
1.5
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
84
635
1.51
2.26
5.7
5.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
57
399
1.57
2.16
3.9
4.0
e6/l
7.1
7.2
0.02
43
351
(36304419) Bacteria [Presence] in Urine
76
581
1.46
1.88
4.2
5.0
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
5
12
4.23
1.83
1.0
1.0
g/l
147.4
163.4
—
5
12
(3022670) pH of Venous cord blood
8
29
2.82
1.81
1.0
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
24
384
0.58
1.75
2.8
5.0
inr
1.1
1.1
—
7
91
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72
556
1.43
1.67
12.2
12.6
mmol/l
1.4
1.0
0.73
47
389
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
142
0.41
1.58
1.7
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
53
390
1.47
1.58
2.8
3.8
mosm/kgh2o
545.8
575.6
0.30
38
338
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
12
57
2.16
1.58
1.0
1.0
g/l
162.5
166.5
0.39
12
57
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
42
0.00
1.54
0.0
2.3
—
13.8
—
0
42
(3013336) Amino acids [Identifier] in Serum or Plasma
0
44
0.00
1.53
0.0
2.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
88
715
1.37
1.50
6.0
6.2
e6/l
73.3
47.0
0.22
61
478
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
52
386
1.45
1.48
3.8
4.6
e6/l
1.7
2.1
0.17
31
228
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
134
1.71
1.45
1.4
1.5
—
—
—
0
0
(3020891) Body temperature
0
40
0.00
1.34
0.0
8.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
48
2.13
1.29
1.6
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
5
115
0.42
1.29
2.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
56
2.01
1.24
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
57
1.98
1.19
1.0
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
384
1.38
1.18
3.8
4.4
e6/l
0.3
0.9
2.19
29
225
(3005719) IgG [Mass/volume] in Serum or Plasma
16
256
0.60
1.18
2.9
5.2
g/l
9.0
8.3
0.40
16
250
(3000330) Specific gravity of Urine by Test strip
10
50
2.04
1.18
1.8
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
70
845
0.75
1.17
3.2
2.9
mmol/l
1.5
1.4
0.46
65
796
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
39
2.09
1.16
1.8
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
39
2.09
1.16
1.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
38
501
0.71
1.12
3.5
2.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
42
316
1.40
1.12
3.4
5.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
27
378
0.68
1.10
2.2
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
32
2.22
1.09
1.6
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
6
122
0.48
1.09
4.5
1.7
e9/l
3.5
4.2
—
6
115
(3022313) Gas panel - Capillary blood
62
501
1.32
1.06
13.1
12.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
20
131
1.58
1.03
1.7
1.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
11
185
0.57
0.99
1.5
1.2
iu/ml
15.6
18.2
—
5
45
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
23
2.20
0.98
1.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
23
2.20
0.98
1.6
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
23
2.20
0.98
1.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
69
1.78
0.98
1.2
2.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
30
0.00
0.98
0.0
2.5
—
1.1
—
0
30
(3037121) Protein [Mass/volume] in Urine
19
125
1.57
0.97
8.4
9.0
g/l
0.3
0.4
0.10
14
110
(3023511) Choriogonadotropin [Units/volume] in Urine
6
120
0.49
0.96
1.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
37
1.92
0.95
1.6
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
7
37
1.92
0.95
1.4
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
37
1.92
0.95
1.6
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
27
2.25
0.94
3.0
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
55
1.85
0.93
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
29
2.10
0.90
1.0
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
82
702
1.26
0.89
7.9
11.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
31
406
0.73
0.88
7.0
5.2
mmol/l
7.0
8.2
0.63
31
379
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
166
0.58
0.87
2.2
2.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
8
138
0.56
0.86
5.0
2.3
—
76.2
—
0
8
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
65
1.73
0.84
1.2
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
14
211
0.64
0.83
2.6
2.4
g/l
0.9
1.0
0.28
14
206
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
24
0.00
0.79
0.0
6.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
33
1.84
0.79
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
33
1.84
0.79
3.0
1.5
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.6
—
19.7
—
0
10
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
26
0.00
0.79
0.0
1.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
26
0.00
0.79
0.0
3.2
—
1.7
—
0
26
(3016879) Cocaine [Presence] in Urine
13
196
0.64
0.78
2.0
2.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
27
0.00
0.78
0.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
135
0.58
0.76
5.4
2.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
24
2.11
0.75
8.2
6.8
ug/l
31.0
24.2
—
5
24
(4306422)
5
24
2.11
0.75
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
479
0.78
0.72
3.2
2.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
26
1.94
0.71
1.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
58
1.57
0.70
1.9
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
213
0.68
0.69
1.9
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
213
0.68
0.69
1.9
1.9
—
—
—
0
0
(4198724)
5
28
1.80
0.66
1.4
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
211
0.69
0.66
1.9
1.9
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
30
1.68
0.61
7.8
12.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
51
1.59
0.61
1.6
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
51
1.59
0.61
1.6
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
51
1.59
0.61
1.6
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
51
1.59
0.61
1.6
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
17
229
0.72
0.59
4.2
15.5
%
93.2
90.1
0.18
17
229
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
176
1.34
0.59
1.3
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
23
0.00
0.58
0.0
6.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
14
98
1.46
0.58
10.9
7.7
%
0.0
0.0
—
7
32
(3014007) Fractional oxyhemoglobin in Arterial blood
5
86
0.57
0.57
20.2
19.8
%
97.4
95.2
—
5
86
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
88
0.56
0.57
20.2
19.4
%
1.1
1.0
—
5
88
(3013707) Erythrocyte sedimentation rate by Westergren method
107
1163
0.85
0.57
5.0
4.4
mm/h
5.2
7.9
7.11
100
1076
(3021387) Prolactin [Units/volume] in Serum or Plasma
16
116
1.41
0.56
1.4
1.6
mu/l
647.1
366.8
0.48
16
109
(3011288) Drugs identified in Urine by Screen method
11
158
0.68
0.55
2.5
2.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
213
0.73
0.53
1.9
2.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
40
1.51
0.52
6.5
3.4
e9/l
3.0
2.9
—
6
40
(3016038) Potassium [Moles/volume] in Urine
6
40
1.51
0.52
2.8
2.8
mmol/l
26.5
34.5
—
6
40
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
40
1.51
0.52
6.7
3.6
%
45.7
48.1
—
6
40
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
55
627
0.84
0.51
4.4
5.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
23
288
0.78
0.50
3.0
3.0
nmol/l
295.7
345.7
0.76
23
276
(3013115) Eosinophils [#/volume] in Blood
129
1204
1.16
0.50
10.1
12.5
e9/l
0.2
0.2
1.96
108
998
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
155
1626
0.86
0.48
8.5
10.1
u/l
22.7
24.8
0.89
148
1560
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
108
997
1.16
0.48
2.0
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
296
0.79
0.47
2.8
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
12
164
0.72
0.47
1.4
1.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
13
94
1.41
0.47
1.3
2.6
pmol/l
5.3
5.1
0.19
13
83
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
19
148
1.31
0.45
1.4
1.5
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
7
51
1.38
0.44
1.4
1.3
u/ml
12.1
5.2
—
7
46
(3050129) First trimester maternal screen panel - Serum or Plasma
6
91
0.65
0.43
1.8
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
31
1.63
0.43
1.8
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
205
2096
0.80
0.43
18.1
19.0
e9/l
7.1
7.1
0.03
198
1981
(3022621) pH of Urine by Test strip
10
70
1.45
0.42
1.6
2.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
14
105
1.35
0.42
10.9
7.6
%
1.0
0.4
—
7
37
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
58
1.39
0.42
5.9
6.3
ug/l
2.8
2.6
—
8
58
(3012516) Albumin [Mass/volume] in Urine
10
138
0.71
0.42
3.9
3.9
mg/l
47.2
243.3
—
10
108
(3032641) Amino acids panel - Urine
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(44813793)
5
34
1.48
0.40
1.0
1.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
205
2094
0.81
0.40
17.9
19.0
e12/l
4.6
4.6
0.98
198
1978
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
18
0.00
0.40
0.0
2.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
2.6
—
8.6
—
0
18
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
136
0.72
0.39
4.2
2.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
152
1.27
0.38
1.4
1.3
iu/ml
301.4
168.9
—
5
44
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
277
0.81
0.38
1.9
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
100
931
1.13
0.38
10.4
12.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
70
1.30
0.37
1.4
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
101
942
1.13
0.37
14.6
16.1
mmol/l
1.2
1.2
0.94
94
880
(3020393) Adenovirus Ag [Presence] in Stool
9
71
1.28
0.36
1.4
2.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
76
0.65
0.36
15.8
3.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
76
0.65
0.36
2.4
3.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
205
2091
0.82
0.36
18.0
19.1
e9/l
284.8
274.6
1.21
198
1985
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
70
641
1.13
0.34
1.7
1.9
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
6
89
0.67
0.33
17.2
19.2
%
0.6
0.7
—
6
89
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
46
1.31
0.33
2.3
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
132
0.75
0.33
1.8
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
37
419
0.86
0.32
2.2
3.3
ug/g
53.0
76.4
0.68
32
333
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
47
1.28
0.32
5.3
5.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
98
919
1.11
0.32
14.2
17.8
mmol/l
1.3
1.2
1.42
92
877
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
18
218
0.81
0.32
2.6
5.6
ng/l
39.1
1191.3
—
10
134
(40768797) Stomach Pathology biopsy report
10
131
0.75
0.32
1.3
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
52
1.36
0.31
8.7
11.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
181
1858
0.88
0.31
12.1
12.8
mg/l
21.0
24.1
0.59
131
1265
(3006315) Basophils [#/volume] in Blood
123
1170
1.11
0.30
9.9
11.2
e9/l
0.0
0.0
0.39
101
947
(3026008) Bacteria identified in Urine by Culture
50
452
1.13
0.30
2.3
2.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
80
745
1.11
0.29
3.6
3.9
estimate
0.0
0.0
—
7
122
(3003694) ABO and Rh group [Type] in Blood
55
601
0.89
0.29
1.6
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
123
1172
1.10
0.29
9.9
11.2
e9/l
0.6
0.6
0.50
101
949
(3037467) Urinalysis macro (dipstick) panel - Urine
113
1073
1.10
0.28
6.0
4.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
9
117
0.76
0.28
1.2
1.8
mmol/l
2.4
2.4
—
9
88
(3013650) Neutrophils [#/volume] in Blood by Automated count
130
1244
1.10
0.28
11.2
13.6
e9/l
3.3
3.4
0.26
106
1014
(3035933) Granulocytes/100 leukocytes in Blood
8
64
1.26
0.28
1.1
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
65
1.24
0.27
2.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
95
1.28
0.26
1.2
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
78
829
0.91
0.25
9.0
6.4
ml/min/173m2
116.1
114.1
0.27
45
495
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
76
1.19
0.25
1.6
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
19
222
0.84
0.24
3.1
7.0
e9/l
49.3
65.7
1.27
12
142
(3000991) Gas panel - Venous blood
44
482
0.89
0.24
10.1
13.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
77
1.18
0.24
2.8
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
78
1.29
0.24
1.1
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
34
378
0.88
0.24
3.7
3.5
kg/l
1.0
1.0
0.31
14
69
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
16
189
0.83
0.23
2.0
2.5
ng/l
9.0
68.9
—
7
69
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
38
1.32
0.23
2.0
2.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
84
887
0.92
0.23
1.7
1.9
u/ml
1.9
3.5
0.69
13
142
(3025159) Blasts/100 leukocytes in Blood
12
97
1.25
0.23
12.3
7.7
%
0.0
0.0
—
5
28
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
46
421
1.12
0.23
3.0
4.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
79
744
1.09
0.23
5.2
5.7
estimate
0.0
0.0
0.00
11
127
(3002032) Base excess in Venous blood by calculation
48
521
0.90
0.23
8.8
13.4
mmol/l
0.7
0.9
0.16
39
396
(4035726)
7
93
0.74
0.23
2.6
2.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
90
945
0.92
0.21
2.5
2.2
mmol/l
5.3
5.3
0.10
82
851
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
42
1.19
0.21
1.6
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
50
462
1.10
0.21
2.8
3.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
108.6
—
0
11
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
10
0.00
0.21
0.0
3.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(4010399)
11
89
1.25
0.21
1.2
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
208
0.85
0.21
2.4
2.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
43
1.17
0.21
1.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
43
1.17
0.21
2.0
2.7
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
79
748
1.08
0.20
3.7
3.9
estimate
0.0
0.0
0.00
11
125
(3008401) Mugwort IgE Ab [Units/volume] in Serum
22
193
1.15
0.20
1.1
1.3
u/ml
0.4
0.8
0.45
16
143
(3003888) Timothy IgE Ab [Units/volume] in Serum
22
193
1.15
0.20
1.1
1.3
u/ml
5.8
6.7
0.07
17
149
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
1.5
—
0
9
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
311.9
—
0
14
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
165
0.84
0.20
2.6
2.2
u/ml
427.3
174.9
—
6
82
(3007164) IgA [Mass/volume] in Serum or Plasma
82
861
0.93
0.19
1.8
1.8
g/l
1.5
1.4
0.24
38
444
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
51
1.18
0.19
1.2
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
100
1.21
0.18
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
58
1.21
0.18
1.7
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
39
359
1.10
0.18
5.8
5.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
119
1.19
0.18
1.6
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
18
205
0.87
0.18
2.4
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
29
319
0.90
0.18
2.5
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
68
0.73
0.17
2.6
2.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
22
196
1.13
0.17
2.1
2.1
—
—
—
0
0
(3000492) Spirometry study
12
101
1.20
0.17
1.7
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
24
266
0.89
0.16
3.1
4.4
u/l
316.8
348.8
0.07
24
260
(36660697) Celiac disease serology panel - Serum
36
389
0.91
0.16
1.3
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
51
542
0.92
0.16
7.8
11.1
g/l
37.2
37.4
0.08
51
520
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
76
0.78
0.16
1.5
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
77
0.77
0.16
4.0
5.5
%
104.2
93.9
—
6
77
(3022145) Colonoscopy Study observation
6
79
0.75
0.16
1.7
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
78
1.16
0.15
1.1
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
78
1.16
0.15
1.8
2.1
—
—
—
0
0
(44790047)
7
88
0.79
0.15
2.6
2.4
—
—
—
0
0
(44790048)
7
88
0.79
0.15
2.6
2.4
—
—
—
0
0
(44790049)
7
88
0.79
0.15
2.6
2.4
—
—
—
0
0
(44806118)
7
88
0.79
0.15
2.6
2.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
22
243
0.89
0.14
2.2
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
118
0.84
0.14
2.2
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
30
325
0.91
0.14
1.9
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
100
0.79
0.14
2.4
2.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
47
497
0.93
0.13
3.4
3.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
195
1924
1.08
0.13
14.4
18.5
%
39.3
38.4
1.76
175
1727
(3013512) EKG study
19
172
1.11
0.11
2.2
2.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
23
211
1.10
0.11
1.1
1.3
u/ml
2.7
2.7
0.00
16
145
(3016244) Insulin [Units/volume] in Serum or Plasma
12
105
1.15
0.11
2.6
3.2
mu/l
18.1
23.0
0.21
12
95
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
167
0.89
0.11
2.4
2.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
27
289
0.93
0.10
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
44
1.14
0.10
1.6
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
47
1.06
0.09
1.8
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
38
361
1.06
0.09
4.0
3.9
estimate
0.0
0.0
—
9
124
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
32
302
1.07
0.09
3.1
8.0
mg/l
1.3
2.7
0.95
20
225
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
62
0.80
0.08
1.4
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
11
123
0.89
0.08
1.0
1.1
u/ml
14.1
9.0
—
5
76
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
6
70
0.85
0.08
1.5
1.4
u/ml
5.5
29.1
—
6
54
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
75
1.07
0.07
2.3
2.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
149
1469
1.04
0.07
3.8
3.7
mu/l
2.1
2.1
0.21
137
1377
(3019198) Lymphocytes [#/volume] in Blood
122
1199
1.04
0.07
10.0
11.2
e9/l
2.8
2.5
0.71
103
1006
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
84
1.07
0.07
3.7
2.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
118
1.11
0.07
2.9
3.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
90
0.88
0.07
1.3
3.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
93
0.85
0.07
1.1
2.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
49
473
1.05
0.07
3.3
4.9
—
—
—
0
0
(3015736) pH of Urine
62
602
1.04
0.06
3.6
3.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
180
1816
0.96
0.06
17.3
19.1
%
13.4
13.2
1.16
175
1791
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
100
0.90
0.06
2.2
2.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
27
284
0.94
0.06
2.1
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
28
291
0.96
0.04
2.3
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
50
512
0.97
0.04
2.8
2.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
32
331
0.96
0.04
17.6
16.3
mmol/l
4.8
5.0
0.12
32
323
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
50
511
0.97
0.03
2.4
3.4
mg/l
2.7
2.7
0.10
43
460
(3035637) Corticotropin [Mass/volume] in Plasma
11
118
0.93
0.03
1.5
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
63
639
0.98
0.02
2.6
2.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
132
1329
0.98
0.02
3.4
3.3
pmol/l
14.6
14.4
0.40
116
1212
(40761511) CBC panel - Blood by Automated count
181
1818
0.98
0.02
9.7
9.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
33
338
0.97
0.02
4.2
3.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
10
93
1.08
0.02
14.2
14.0
mmol/l
22.3
23.1
—
10
86
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
117
0.94
0.02
2.3
2.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
33
322
1.03
0.02
1.8
1.6
pmol/l
107.8
97.2
0.79
19
164
(3009214) Lutropin [Units/volume] in Serum or Plasma
17
163
1.05
0.01
2.2
2.4
u/l
5.7
5.3
0.14
12
104
(3028707) Methadone [Presence] in Urine by Screen method
10
104
0.96
0.00
2.3
2.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
244
0.98
0.00
2.5
2.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
142
0.98
0.00
1.9
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
340
1.00
0.00
2.6
2.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
76
760
1.00
0.00
4.3
3.3
mmol/mol
34.3
36.7
1.46
71
716
(3010726) Horse dander IgE Ab [Units/volume] in Serum
20
195
1.03
0.00
1.2
1.2
u/ml
0.3
3.7
—
5
72
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
146
1.03
0.00
1.5
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
163
0.98
0.00
1.2
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
15
145
1.04
0.00
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
196
1955
1.01
0.00
4.1
3.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
113
1134
0.99
0.00
11.6
13.1
e9/l
0.0
0.0
0.51
85
845
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
6
0.00
0.00
0.0
1.7
—
14.8
—
0
6
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
6
0.00
0.00
0.0
1.2
—
1.0
—
0
6
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
8.0
—
0
6
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
67
0.89
0.00
1.5
5.7
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
6
0.00
0.00
0.0
4.5
—
14.7
—
0
6
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
112.0
—
0
6
(40768795) Lymph node Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(4146454)
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
97
0.92
0.00
2.0
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
58
0.86
0.00
2.4
4.8
umol/l
24.8
25.2
—
5
58
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
51
0.98
0.00
1.4
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.2
—
4.9
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
20.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
8
0.00
0.00
0.0
1.5
—
13.2
—
0
8
(3013862) HLA-DP [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
1.9
—
0
5
(40760409) HLA-A [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
81
0.99
0.00
1.9
2.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
81
0.99
0.00
2.1
6.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
6.6
—
4.5
—
0
5
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
1.7
—
0
7
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
14.2
—
39.4
—
0
5
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
51
0.98
0.00
1.4
1.2
%
58.8
78.6
—
5
51
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019225) pH of Specimen
6
64
0.94
0.00
13.2
4.3
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
90
1.00
0.00
1.0
1.1
—
9.1
—
0
17
(40763791) Oxygen content in Venous blood by calculation
0
5
0.00
0.00
0.0
2.2
—
16.5
—
0
5
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
9
93
0.97
0.00
1.8
1.4
g/l
1.1
1.2
—
9
88
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
8
88
0.91
0.00
2.3
5.8
mg/l
261.8
391.1
—
8
88
(40763590) HLA-DQ beta [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
3.0
—
0.9
—
0
5
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_FET_NEWB_MATERN_COMPLICATIO_PREGNAC and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_FET_NEWB_MATERN_COMPLICATIO_PREGNAC.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_FET_NEWB_MATERN_COMPLICATIO_PREGNAC – Fetus and newborn affected by maternal complications of pregnancy
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data